Antitrust experts from across the globe convened in Washington, D.C. on April 2–4, 2025 to discuss new enforcement policies and share updates on current issues in antitrust. We provide the key highlights from numerous panels...more
4/9/2025
/ Acquisitions ,
Antitrust Division ,
Antitrust Violations ,
Biden Administration ,
Cartels ,
Competition ,
Department of Justice (DOJ) ,
Enforcement Actions ,
EU ,
Federal Trade Commission (FTC) ,
Mergers ,
No-Poaching ,
Pharmaceutical Industry ,
Popular ,
Tariffs ,
Technology Sector ,
Trump Administration
Throughout the first half of 2020, much of the world has grappled with the reality of the coronavirus (COVID-19) pandemic, as the outbreak spread rapidly across entire countries and shut down large segments of the global...more
7/7/2020
/ ACPERA ,
Antitrust Provisions ,
Coronavirus/COVID-19 ,
Department of Justice (DOJ) ,
DPA ,
Pharmaceutical Industry ,
Price-Fixing ,
Remote Working ,
UK ,
UK Competition and Markets Authority (CMA) ,
Whistleblower Protection Policies